The store will not work correctly when cookies are disabled.
(RR/SS)-2-[1-(3,4-dichlorophenyl)-3-methylbutyl]-piperidine
ID: ALA218999
PubChem CID: 16102766
Max Phase: Preclinical
Molecular Formula: C16H23Cl2N
Molecular Weight: 300.27
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)CC(c1ccc(Cl)c(Cl)c1)C1CCCCN1
Standard InChI: InChI=1S/C16H23Cl2N/c1-11(2)9-13(16-5-3-4-8-19-16)12-6-7-14(17)15(18)10-12/h6-7,10-11,13,16,19H,3-5,8-9H2,1-2H3
Standard InChI Key: MXBQNIQYUCTYND-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
2.4973 -0.8459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2157 -0.4349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9312 -0.8488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6491 -0.4385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6507 0.3905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9286 0.8075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2136 0.3907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7849 -0.4319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7886 0.3940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0802 0.8078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3631 0.4013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3589 -0.4237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4946 -1.6699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3613 -0.8528 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1.7796 -2.0795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0674 -1.6651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3647 0.8018 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1.0702 -0.8411 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7769 -2.9034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4 5 2 0
2 3 2 0
5 6 1 0
8 18 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 18 1 0
1 2 1 0
1 13 1 0
6 7 2 0
4 14 1 0
7 2 1 0
13 15 1 0
3 4 1 0
15 16 1 0
1 8 1 0
5 17 1 0
8 9 1 0
15 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 300.27 | Molecular Weight (Monoisotopic): 299.1208 | AlogP: 5.27 | #Rotatable Bonds: 4 |
Polar Surface Area: 12.03 | Molecular Species: BASE | HBA: 1 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 1 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 10.22 | CX LogP: 5.48 | CX LogD: 2.80 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.80 | Np Likeness Score: 0.02 |
References
1. Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A.. (2007) Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter., 50 (2): [PMID:17228864] [10.1021/jm0608614] |
2. Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A.. (2007) Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter., 50 (2): [PMID:17228864] [10.1021/jm0608614] |